Bennett W D, Smaldone G C
Department of Medicine, State University of New York, StonyBrook 11794.
J Appl Physiol (1985). 1988 Apr;64(4):1554-60. doi: 10.1152/jappl.1988.64.4.1554.
Using in vivo measures of aerosol recovery (RC) as a function of breath-hold time (t) (Gebhart et al. J. Appl. Physiol. 51: 465-476, 1981), we estimated the mean diameter (D) of the pulmonary air spaces in subjects diagnosed with chronic obstructive pulmonary disease (COPD) (n = 8) and in subjects with normal pulmonary function (n = 10). For each subject, RC (aerosol expired/aerosol inspired) decreased exponentially with t. Based on a model of the lung as a system of randomly oriented cylindrical tubes, the half time (t1/2) (i.e., the breath-hold time to reach 50% of RC with no breath hold) is proportional to a mean diameter (D) of air spaces filled with aerosol. Subjects with normal pulmonary function had a mean t1/2 = 6.5 +/- 0.8 s, corresponding to a mean D = 0.36 +/- 0.05 mm. On the other hand, subjects with COPD had a mean t1/2 = 12.7 +/- 3.2 s, corresponding to a mean D = 0.70 +/- 0.18 mm [i.e., twice as large (P less than 0.01) as normal subjects]. Furthermore, D correlated significantly with diffusing capacity in the patients with COPD (r = -0.95, P less than 0.001 for D vs. percent predicted diffusing capacity of CO) but not with any other measure of pulmonary function. In contrast, D varied only slightly in normals and did not correlate with any measure of pulmonary function. We conclude that in vivo measures of RC vs. t, in conjunction with other pulmonary function tests, may be a useful tool for identifying actual changes in pulmonary air-space sizes associated with pulmonary disease.
我们利用体内气溶胶回收量(RC)作为屏气时间(t)的函数的测量方法(Gebhart等人,《应用生理学杂志》51: 465 - 476,1981),估算了被诊断为慢性阻塞性肺疾病(COPD)的受试者(n = 8)和肺功能正常的受试者(n = 10)肺内气腔的平均直径(D)。对于每个受试者,RC(呼出气溶胶/吸入气溶胶)随t呈指数下降。基于将肺视为随机取向的圆柱形管道系统的模型,半衰期(t1/2)(即无屏气时达到RC的50%的屏气时间)与充满气溶胶的气腔平均直径(D)成正比。肺功能正常的受试者平均t1/2 = 6.5 ± 0.8秒,对应的平均D = 0.36 ± 0.05毫米。另一方面,COPD受试者平均t1/2 = 12.7 ± 3.2秒,对应的平均D = 0.70 ± 0.18毫米[即比正常受试者大两倍(P < 0.01)]。此外,在COPD患者中,D与弥散能力显著相关(r = -0.95,D与CO预测弥散能力百分比相比,P < 0.001),但与任何其他肺功能指标均无相关性。相比之下,正常受试者中D变化很小,且与任何肺功能指标均无相关性。我们得出结论,体内RC与t的测量方法,结合其他肺功能测试,可能是识别与肺部疾病相关的肺内气腔大小实际变化的有用工具。